Taylor Atchley, MD
Allergy & Immunology · Chattanooga, TNNPI 1972923860
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.0% of the total across 146 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 29.4% of the total. 2025 is the largest year on record at $1,810, more than ten times the $29 reported in 2022. That places this record below the midpoint for allergy & immunology clinicians in TN, where the typical reported total is $6,300.
Across 146 payments — averaging $24.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$1K
- AstraZeneca$721
- Sanofi$581
- Novartis$309
- CSL Behring$170
- GSK$170
- plus $555 from 14 others
What the payments were for
- Food & beverage$3,51799%
- Education$351%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 39 | $1,046 |
| AstraZeneca | 28 | $721 |
| Sanofi | 22 | $581 |
| Novartis | 14 | $309 |
| CSL Behring | 7 | $170 |
| GSK | 12 | $170 |
| Genentech USA, Inc. | 4 | $107 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $97 |
| Biocryst US Sales Co., LLC | 3 | $63 |
| Cycle Pharmaceuticals Inc | 2 | $46 |
| Amgen | 2 | $43 |
| Pharming Healthcare, Inc. | 1 | $31 |
| Pfizer | 1 | $30 |
| Aimmune Therapeutics, Inc. | 1 | $25 |
| X4 Pharmaceuticals, Inc. | 1 | $24 |
| Ionis Pharmaceuticals, Inc. | 1 | $22 |
| Sanofi Pasteur Inc. | 1 | $21 |
| Galderma Laboratories, L.p. | 1 | $18 |
| Optinose US, Inc. | 1 | $15 |
| Merck | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FASENRA$122
How this compares
$3,552 in reported general payments places this provider in the 35th percentile of 79 allergy & immunology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 20 | $73,635 |
| Dupixent PenDupilumab | 12 | $52,408 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 49 | $51,460 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 11 | $8,254 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 25 | $6,299 |
| Azelastine Hcl | 58 | $2,456 |
| Fluticasone Propionate | 100 | $2,389 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 42 | $1,037 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $170 | $51,46049 claims |
| AstraZenecaBreztri Aerosphere | $721 | $8,25411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 79 allergy & immunology providers in Tennessee.
Other allergy & immunology in Chattanooga
- Marc CromieChattanooga$106K
- Todd LevinChattanooga$64K
- Susan RaschalChattanooga$40K
- Jennifer PatelChattanooga$12K
- Lee PerryChattanooga$10K
- Joseph WisniewskiChattanooga$6K
- David ChaffinChattanooga$5K
- Jessica van MasonChattanooga$5K
- Michael HollieChattanooga$3K
- Paul CarterChattanooga$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.